Test
AIM ImmunoTech, Inc. operates as a biopharmaceutical company, which engages in the clinical development of new drug therapies based on natural immune system enhancing technologies for the treatment of viral and immune based disorders. Its products include Alferon N Injection and Ampligen. The Alferon N Injection is a purified, natural source, glycosylated,...
Predator Oil Share Trades (PRD) over sold scenario
we have gone done too far and could be looking at a trendline bounce. Give it a few days for the most recent news to digest before investors will be looking to re enter at these low levels.
As we approach the upper band of the channel we can start to anticipate a break . Backed by increase of volume we could see the SP break out shortly . I Will keep a close on on these shares and look for a possible entry. Aggressive traders will be looking enter now. Target 1 would be around 8.5 with target 2 around 15.
Market kelihatan menarik tetapi ada halangan besar yang boleh terjadi bila bila masa. berikutan adanya kewujudan GAP yang amat besar.trend masih lagi uptrend, price bermain sekitar 0.255, dari segi analisis harga mampu bergerak sehingga 0.350. dari segi major trend pula, kemungkinan harga akan melakukan retracement sekiranya ada berita yang memberi kesan buruk...
Guys are waiting for a short on January 5-12, then sell on February 1-25 at 2.14-2.33 and get a profit of 35-55%. If it's not difficult for you to rate my analytics and + REP if not difficult) I am not a professional analyst but I do what I can!
Let's run through some indicators to flesh out a potential fractal whereby the share price enters a trading range around the current level before going on a moon mission (most likely triggered by Togo news and ongoing newsflow from Utah):
1. RSI - Sub-30 in March and settling at 40. Prior to this, the RSI has always bounced off 30. However, the last time it went...
$AIM might be looking at a potential long if MACD can cross up on the daily and volume can get in running up to earnings next Monday. Looking for exit before then.
Keep in mind this is strictly opinion and not investment advice.
Despite having a history of running up exponentially -- and leaving "bagholders" in it's wake; the past couple of months have been relatively quiet. And look where price is now. I like stocks that creep up in price because they're kind of predictable (until they're not). AIM is one news story away from blowing out of that triangle. Any day now, AIM.
AIM is one of the stocks that have underwhelmed me in performance lately. However given current resistance wedges, I think as an entry point right now it would seem low to mid risk. I believe going in as a long hold, you can expect some positive retracement, and quite possibly a $3.15 price target by end of August. That being said, pursue at your own risk. As...
First off, please don't take anything I say seriously or as financial advice. As always, this is on an opinion based basis. That being said at a buy entry now, than sell good till canceled order at $3.85, I think something like this can actually be reached quite soon. AIM started having some strong support, and you can start seeing accumulation growth, and likely...
1. Compare the chart to the Wall Street Cheat Sheet and looks like we're in the Depression phase. Quiet on Twitter and bitter sentiment on LSE/ADVFN, nice contrarian signals and not a crowded trade.
2. POC at 1.4p. Sharp capitulation from January to Mid-March where RSI hit 18 and has recovered slightly.
3. Upcoming catalysts: OGA 32nd Offshore Licensing results...
